The NF-κB-IL-6-STAT3 signaling pathway promotes the proliferation and survival of tumor-initiating cells in the intestinal epithelium and protects them from apoptosis, thereby facilitating tumor growth and progression. Here, NFKB1 is linked to neoplasm.